Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Hannah Lui Park

Photo of Hannah Lui Park
Title(s)Associate Professor In Residence, Pathology
SchoolSchool of Medicine
Address1001 Health Sciences Road
Irvine CA 92697-3950
Phone(949) 824-2651
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    Stanford UniversityPh.D.2003Biological Sciences
    University of Southern California Keck School of MedicineM.S.1999Cell and Neurobiology
    University of California, BerkeleyB.A.1997Molecular and Cell Biology

    Collapse Research 
    Collapse research activities and funding
    All of Us Southern California Consortium (AoUSCC): Engagement, Enrollment, and Retention of Diverse Populations
    NIH OT2OD036428May 1, 2024 - Jul 31, 2026
    Role: Co-Principal Investigator
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. WISDOM randomized trial comparing risk-based versus annual breast cancer screening: study cohort characteristics and design. NPJ Breast Cancer. 2026 May 24. Fiscalini A, Blum K, Fergus K, Hiatt RA, Naeim A, Kaster A, Scheuner MT, van 't Veer LJ, LaCroix AZ, Borowsky AD, Olopade OI, Park HL, Esserman J, Lancaster R, Heditsian D, Brain S, Lee V, Goodman DL, Ross KS, Wenger N, Parker BA, Madlensky L, Tice JA, Shieh Y, Ziv E, Arasu VA, Anton-Culver H, Kaplan CP, Rhoads KF, Badal K, Hogarth M, Petruse A, Soto IA, Leggat-Barr K, Goodman S, Atamer J, Ryu R, Adduci K, Matthews JB, Eklund M, Athena/WISDOM Network Collaborators and Advocate Partners, Sabacan LP, Esserman L. PMID: 42177197.
      View in: PubMed   Mentions:
    2. Risk-Based vs Annual Breast Cancer Screening: The WISDOM Randomized Clinical Trial. JAMA. 2026 03 03; 335(9):763-774. Esserman LJ, Fiscalini AS, Naeim A, Van't Veer LJ, Kaster A, Scheuner MT, LaCroix AZ, Borowsky AD, Anton-Culver H, Olopade OI, Esserman J, Lancaster R, Madlensky L, Blanco AM, Ross KS, Goodman DL, Tong BS, Hogarth M, Heditsian D, Brain S, Lee V, Blum K, Kim MO, Sabacan LP, Fergus KB, Yau C, Park HL, Parker BA, Kaplan C, Rhoads KF, Eder S, Adduci K, Matthews JB, Wenger NS, Shieh Y, Hiatt RA, Ziv E, Tice JA, Eklund M. PMID: 41385349; PMCID: PMC12701531.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    3. Germline Pathogenic Variants Among Women Without a History of Breast Cancer: A Secondary Analysis of the WISDOM Randomized Clinical Trial. JAMA Intern Med. 2026 Mar 01; 186(3):344-352. Fergus KB, Ross KS, Scheuner MT, Blanco AM, Tice JA, Ziv E, Shieh Y, van 't Veer L, Olopade OI, Goodman DL, Tong BS, Harvey H, DeRosa D, Risty L, Silver E, Kaster A, Fiscalini AS, Blum K, Heise R, Sabacan L, Heditsian D, Brain S, Petruse A, Eklund M, Hiatt RA, Borowsky AD, Naeim A, Park HL, LaCroix AZ, Parker BA, Lancaster R, Esserman J, Wenger N, Arasu V, Anton-Culver H, Esserman LJ, Madlensky L. PMID: 41385723; PMCID: PMC12701530.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. UC Irvine's Brain Initiative Cell Atlas Network (BICAN) Brain Procurement Program for the Center for Multiomic Human Brain Cell Atlas Project. bioRxiv. 2025 Dec 26. Berry JV, Tran BM, Wu G, Tan Z, Mendoza E, Kim M, Arat Z, Lin PSH, Valenzuela L, Holmes TC, Virovka A, Thaxton M, Nguyen M, Stein S, Sigaroudi VR, De La Rosa A, Gawronski B, Silva J, Gonzalez L, Wright S, Wood K, Hui GK, Anousaya D, Gangeddula VR, Gama N, Gama J, Gross T, Bunney B, Stein R, Sequeira PA, Mamdani F, Cartagena P, Bunney WE, Lou J, Park HL, Wilson A, Brooks HM, Allhusen V, Crawford J, Knight JM, Ren B, Ecker J, Behrens MM, Keene CD, Stark C, Head E, Yong W, Monuki E, Xu X. PMID: 41509448; PMCID: PMC12776169.
      View in: PubMed   Mentions:
    5. WISDOM Randomized Trial Comparing Risk-Based Versus Annual Breast Cancer Screening: Study Cohort Characteristics and Design. Res Sq. 2025 Dec 15. Fiscalini A, Blum K, Fergus K, Hiatt RA, Naeim A, Kaster A, Scheuner MT, van 't Veer LJ, LaCroix AZ, Borowsky AD, Olopade OI, Park HL, Esserman J, Lancaster R, Heditsian D, Brain S, Lee V, Goodman DL, Ross KS, Wenger N, Parker BA, Madlensky L, Tice JA, Shieh Y, Ziv E, Arasu VA, Anton-Culver H, Kaplan CP, Rhoads KF, Badal K, Hogarth M, Petruse A, Soto IA, Leggat-Barr K, Goodman S, Atamer J, Ryu R, Adduci K, Matthews JB, Eklund M, Athena/WISDOM Network Collaborators and Advocate Partners, Sabacan LP, Esserman L. PMID: 41255969; PMCID: PMC12622172.
      View in: PubMed   Mentions:
    6. Hormone therapy use and young-onset breast cancer: a pooled analysis of prospective cohorts included in the Premenopausal Breast Cancer Collaborative Group. Lancet Oncol. 2025 Jul; 26(7):911-923. O'Brien KM, House MG, Goldberg M, Jones ME, Weinberg CR, de Gonzalez AB, Bertrand KA, Blot WJ, DeHart JC, Couch FJ, Garcia-Closas M, Giles GG, Kirsh VA, Kitahara CM, Koh WP, Park HL, Milne RL, Palmer JR, Patel AV, Rohan TE, Schoemaker MJ, Swerdlow AJ, Teras LR, Vachon C, Visvanathan K, Yuan JM, Zheng W, Nichols HB, Sandler DP. PMID: 40609572; PMCID: PMC12233149.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Automated self-service cohort selection for large-scale population sciences and observational research: The California Teachers Study researcher platform. PLoS One. 2025; 20(5):e0296611. Lacey JV, Spielfogel ES, Benbow JL, Savage KE, Lin K, Anderson CAM, Clague-DeHart J, Duffy CN, Martinez ME, Park HL, Thompson CA, Wang SS, Chandra S. PMID: 40354347; PMCID: PMC12068635.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. ALDH2 Deficiency and Alcohol Intake in the United States: Opportunity for Precision Cancer Prevention. Cancer Epidemiol Biomarkers Prev. 2025 May 02; 34(5):744-753. Forman D, Yang M, Chien R, Nguyen H, Wong C, Kim JHJ, Ziogas A, Park HL. PMID: 40063522; PMCID: PMC12048207.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Development and validation of a risk prediction model for premenopausal breast cancer in 19 cohorts. Breast Cancer Res. 2025 May 01; 27(1):67. Brantley KD, Jones ME, Tamimi RM, Rosner BA, Kraft P, Nichols HB, O'Brien KM, Adami HO, Aizpurua A, Berrington de González A, Blot WJ, Braaten T, Chen Y, DeHart JC, Dossus L, Elias S, Fortner RT, Garcia-Closas M, Gram IT, Håkansson N, Hankinson SE, Kitahara CM, Koh WP, Linet MS, MacInnis RJ, Masala G, Mellemkjær L, Milne RL, Muller DC, Park HL, Ruddy KJ, Sandin S, Shu XO, Tin Tin S, Truong T, Vachon CM, Vatten LJ, Visvanathan K, Weiderpass E, Willett W, Wolk A, Yuan JM, Zheng W, Sandler DP, Schoemaker MJ, Swerdlow AJ, Eliassen AH. PMID: 40312753; PMCID: PMC12046669.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Central and peripheral adiposity and premenopausal breast cancer risk: a pooled analysis of 440,179 women. Breast Cancer Res. 2025 Apr 15; 27(1):55. Schoemaker MJ, Ellington T, Nichols HB, Wright LB, Jones ME, O'Brien KM, Weinberg CR, Adami HO, Baglietto L, Bertrand KA, Chen Y, Clague DeHart J, Eliassen AH, Giles GG, Houghton SC, Kirsh VA, Milne RL, Palmer JR, Park HL, Rohan TE, Severi G, Shu XO, Tamimi RM, Vatten LJ, Weiderpass E, Willett WC, Zeleniuch-Jacquotte A, Zheng W, Sandler DP, Swerdlow AJ, Premenopausal Breast Cancer Collaborative Group. PMID: 40234955; PMCID: PMC12001638.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    11. Cell type-specific 3D-genome organization and transcription regulation in the brain. Sci Adv. 2025 Feb 28; 11(9):eadv2067. Liu S, Wang CY, Zheng P, Jia BB, Zemke NR, Ren P, Park HL, Ren B, Zhuang X. PMID: 40009678; PMCID: PMC11864200.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCells
    12. Potential Role of Glyphosate, Glyphosate-Based Herbicides, and AMPA in Breast Cancer Development: A Review of Human and Human Cell-Based Studies. Int J Environ Res Public Health. 2024 Aug 17; 21(8). Schluter HM, Bariami H, Park HL. PMID: 39200696; PMCID: PMC11354939.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    13. BMI and breast cancer risk around age at menopause. Cancer Epidemiol. 2024 Apr; 89:102545. Von Holle A, Adami HO, Baglietto L, Berrington de Gonzalez A, Bertrand KA, Blot W, Chen Y, DeHart JC, Dossus L, Eliassen AH, Fournier A, Garcia-Closas M, Giles G, Guevara M, Hankinson SE, Heath A, Jones ME, Joshu CE, Kaaks R, Kirsh VA, Kitahara CM, Koh WP, Linet MS, Park HL, Masala G, Mellemkjaer L, Milne RL, O'Brien KM, Palmer JR, Riboli E, Rohan TE, Shrubsole MJ, Sund M, Tamimi R, Tin Tin S, Visvanathan K, Vermeulen RC, Weiderpass E, Willett WC, Yuan JM, Zeleniuch-Jacquotte A, Nichols HB, Sandler DP, Swerdlow AJ, Schoemaker MJ, Weinberg CR. PMID: 38377945; PMCID: PMC10942753.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    14. International Pooled Analysis of Leisure-Time Physical Activity and Premenopausal Breast Cancer in Women From 19 Cohorts. J Clin Oncol. 2024 03 10; 42(8):927-939. Timmins IR, Jones ME, O'Brien KM, Adami HO, Aune D, Baglietto L, Bertrand KA, Brantley KD, Chen Y, Clague DeHart J, Clendenen TV, Dossus L, Eliassen AH, Fletcher O, Fournier A, Håkansson N, Hankinson SE, Houlston RS, Joshu CE, Kirsh VA, Kitahara CM, Koh WP, Linet MS, Park HL, Lynch BM, May AM, Mellemkjær L, Milne RL, Palmer JR, Ricceri F, Rohan TE, Ruddy KJ, Sánchez MJ, Shu XO, Smith-Byrne K, Steindorf K, Sund M, Vachon CM, Vatten LJ, Visvanathan K, Weiderpass E, Willett WC, Wolk A, Yuan JM, Zheng W, Nichols HB, Sandler DP, Swerdlow AJ, Schoemaker MJ. PMID: 38079601; PMCID: PMC10927335.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    15. Factors Associated with Longitudinal Changes in Mammographic Density in a Multiethnic Breast Screening Cohort of Postmenopausal Women. Breast J. 2023; 2023:2794603. Park HL, Ziogas A, Feig SA, Kirmizi RL, Lee CJ, Alvarez A, Lucia RM, Goodman D, Larsen KM, Kelly R, Anton-Culver H. PMID: 37881237; PMCID: PMC10597735.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    16. Early Ascertainment of Breast Cancer Diagnoses Comparing Self-Reported Questionnaires and Electronic Health Record Data Warehouse: The WISDOM Study. JCO Clin Cancer Inform. 2023 08; 7:e2300019. Leggat-Barr K, Ryu R, Hogarth M, Stover-Fiscalini A, Veer LV', Park HL, Lewis T, Thompson C, Borowsky A, Hiatt RA, LaCroix A, Parker B, Madlensky L, Naeim A, Esserman L. PMID: 37607323; PMCID: PMC12930483.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    17. Urinary glyphosate and AMPA levels in a cross-sectional study of postmenopausal women: Associations with organic eating behavior and dietary intake. Int J Hyg Environ Health. 2023 07; 252:114211. Lucia RM, Liao X, Huang WL, Forman D, Kim A, Ziogas A, Norden-Krichmar TM, Goodman D, Alvarez A, Masunaka I, Pathak KV, McGilvrey M, Hegde AM, Pirrotte P, Park HL. PMID: 37393842; PMCID: PMC10503538.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    18. Association of Glyphosate Exposure with Blood DNA Methylation in a Cross-Sectional Study of Postmenopausal Women. Environ Health Perspect. 2022 04; 130(4):47001. Lucia RM, Huang WL, Pathak KV, McGilvrey M, David-Dirgo V, Alvarez A, Goodman D, Masunaka I, Odegaard AO, Ziogas A, Pirrotte P, Norden-Krichmar TM, Park HL. PMID: 35377194; PMCID: PMC8978648.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    19. Mammography screening and mortality by risk status in the California teachers study. BMC Cancer. 2021 Dec 18; 21(1):1341. Park HL, Chang J, Haridass V, Wang SS, Ziogas A, Anton-Culver H. PMID: 34922473; PMCID: PMC8684058.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    20. Association of mammographic density with blood DNA methylation. Epigenetics. 2022 05; 17(5):531-546. Lucia RM, Huang WL, Alvarez A, Masunaka I, Ziogas A, Goodman D, Odegaard AO, Norden-Krichmar TM, Park HL. PMID: 34116608; PMCID: PMC9067527.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    21. Factors Associated with Women's Unwillingness to Decrease Alcohol Intake to Decrease Breast Cancer Risk. J Prim Care Community Health. 2021 Jan-Dec; 12:21501327211000211. Matin J, Lucia RM, Lal K, Columbus A, Goodman D, Larsen K, Ziogas A, Park HL. PMID: 33749348; PMCID: PMC7983428.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    22. Breast Cancer Risk Prediction in Korean Women: Review and Perspectives on Personalized Breast Cancer Screening. J Breast Cancer. 2020 08; 23(4):331-342. Kim DY, Park HL. PMID: 32908785; PMCID: PMC7462811.
      View in: PubMed   Mentions: 5  
    23. Organophosphate Pesticide Exposure and Breast Cancer Risk: A Rapid Review of Human, Animal, and Cell-Based Studies. Int J Environ Res Public Health. 2020 07 13; 17(14). Yang KJ, Lee J, Park HL. PMID: 32668751; PMCID: PMC7399930.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimals
    24. Rationale, Study Design, and Cohort Characteristics for the Markers for Environmental Exposures (MEE) Study. Int J Environ Res Public Health. 2020 03 09; 17(5). Lucia RM, Huang WL, Alvarez A, Thampy D, Elyasian M, Hidajat A, Yang K, Forman D, Pebdani A, Masunaka I, Brain S, Heditsian D, Lee V, Goodman D, Norden-Krichmar TM, Odegaard AO, Ziogas A, Park HL. PMID: 32182891; PMCID: PMC7084413.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    25. A treatment-based algorithm for identification of diabetes type in the National Health and Nutrition Examination Survey. Cardiovasc Endocrinol Metab. 2020 Mar; 9(1):9-16. Mosslemi M, Park HL, McLaren CE, Wong ND. PMID: 32104786; PMCID: PMC7041875.
      View in: PubMed   Mentions: 10  
    26. Epigenetic Biomarkers for Environmental Exposures and Personalized Breast Cancer Prevention. Int J Environ Res Public Health. 2020 02 13; 17(4). Park HL. PMID: 32069786; PMCID: PMC7068429.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCellsPHPublic Health
    27. Effective risk communication to promote behavioral change in patients at elevated risk for breast cancer based on the Health Belief Model. Breast J. 2018 11; 24(6):1097-1098. Yang M, Barker K, Goodman D, Park HL. PMID: 30079616.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    28. Trends in Treatment Patterns and Clinical Outcomes in Young Women Diagnosed With Ductal Carcinoma In Situ. Clin Breast Cancer. 2018 04; 18(2):e179-e185. Park HL, Chang J, Lal G, Lal K, Ziogas A, Anton-Culver H. PMID: 28941977; PMCID: PMC7817367.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    29. Recreational physical activity and risk of triple negative breast cancer in the California Teachers Study. Breast Cancer Res. 2016 06 17; 18(1):62. Ma H, Xu X, Clague J, Lu Y, Togawa K, Wang SS, Clarke CA, Lee E, Park HL, Sullivan-Halley J, Neuhausen SL, Bernstein L. PMID: 27317095; PMCID: PMC4912767.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansPHPublic Health
    30. Novel polymorphisms in caspase-8 are associated with breast cancer risk in the California Teachers Study. BMC Cancer. 2016 Jan 12; 16:14. Park HL, Ziogas A, Chang J, Desai B, Bessonova L, Garner C, Lee E, Neuhausen SL, Wang SS, Ma H, Clague J, Reynolds P, Lacey JV, Bernstein L, Anton-Culver H. PMID: 26758508; PMCID: PMC4711015.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    31. Clinical Implementation of a Breast Cancer Risk Assessment Program in a Multiethnic Patient Population: Which Risk Model to Use? Breast J. 2015 Sep-Oct; 21(5):562-4. Park HL, Tran SM, Lee J, Goodman D, Ziogas A, Kelly R, Larsen KM, Alvarez A, Tannous C, Strope J, Lynch W, Anton-Culver H. PMID: 26227105.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    32. Construct validation of the dietary inflammatory index among postmenopausal women. Ann Epidemiol. 2015 Jun; 25(6):398-405. Tabung FK, Steck SE, Zhang J, Ma Y, Liese AD, Agalliu I, Hingle M, Hou L, Hurley TG, Jiao L, Martin LW, Millen AE, Park HL, Rosal MC, Shikany JM, Shivappa N, Ockene JK, Hebert JR. PMID: 25900255; PMCID: PMC4433562.
      View in: PubMed   Mentions: 230     Fields:    Translation:Humans
    33. Human Nail Clippings as a Source of DNA for Genetic Studies. Open J Epidemiol. 2015 Feb 01; 5(1):41-50. Truong L, Park HL, Chang SS, Ziogas A, Neuhausen SL, Wang SS, Bernstein L, Anton-Culver H. PMID: 26180661; PMCID: PMC4499506.
      View in: PubMed   Mentions: 5  
    34. Self-recalled Youth Physical Activity and Postmenopausal Cardiovascular Disease. Health Behav Policy Rev. 2014 Nov; 1(6):472-483. Goodman D, Park HL, Stefanick M, Hingle M, Lamonte M, LeBlanc E, Johnson K, Desai M, Anton-Culver H. PMID: 26523282; PMCID: PMC4627784.
      View in: PubMed   Mentions: 1  
    35. Risk of cardiovascular disease among postmenopausal women with prior pregnancy loss: the women's health initiative. Ann Fam Med. 2014 Jul; 12(4):302-9. Parker DR, Lu B, Sands-Lincoln M, Kroenke CH, Lee CC, O'Sullivan M, Park HL, Parikh N, Schenken RS, Eaton CB. PMID: 25024237; PMCID: PMC4096466.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    36. Evaluation of ultra-deep targeted sequencing for personalized breast cancer care. Breast Cancer Res. 2013 Dec 10; 15(6):R115. Harismendy O, Schwab RB, Alakus H, Yost SE, Matsui H, Hasteh F, Wallace AM, Park HL, Madlensky L, Parker B, Carpenter PM, Jepsen K, Anton-Culver H, Frazer KA. PMID: 24326041; PMCID: PMC3978701.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    37. Relation between self-recalled childhood physical activity and adult physical activity: The women's health initiative. Open J Epidemiol. 2013 Nov 01; 3(4):224-231. Goodman D, Park HL, Stefanick M, LeBlanc E, Bea J, Qi L, Kapphahn K, Lamonte M, Manini T, Desai M, Anton-Culver H. PMID: 26877895; PMCID: PMC4749265.
      View in: PubMed   Mentions: 2  
    38. Prospective analysis of association between statin use and breast cancer risk in the women's health initiative. Cancer Epidemiol Biomarkers Prev. 2013 Oct; 22(10):1868-76. Desai P, Chlebowski R, Cauley JA, Manson JE, Wu C, Martin LW, Jay A, Bock C, Cote M, Petrucelli N, Rosenberg CA, Peters U, Agalliu I, Budrys N, Abdul-Hussein M, Lane D, Luo J, Park HL, Thomas F, Wactawski-Wende J, Simon MS. PMID: 23975947; PMCID: PMC3889164.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    39. Cysteine dioxygenase 1 is a tumor suppressor gene silenced by promoter methylation in multiple human cancers. PLoS One. 2012; 7(9):e44951. Brait M, Ling S, Nagpal JK, Chang X, Park HL, Lee J, Okamura J, Yamashita K, Sidransky D, Kim MS. PMID: 23028699; PMCID: PMC3459978.
      View in: PubMed   Mentions: 78     Fields:    Translation:HumansAnimalsCells
    40. Effects of a dietary intervention and weight change on vasomotor symptoms in the Women's Health Initiative. Menopause. 2012 Sep; 19(9):980-8. Kroenke CH, Caan BJ, Stefanick ML, Anderson G, Brzyski R, Johnson KC, LeBlanc E, Lee C, La Croix AZ, Park HL, Sims ST, Vitolins M, Wallace R. PMID: 22781782; PMCID: PMC3428489.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimals
    41. Angiogenic factor signaling regulates centrosome duplication in endothelial cells of developing blood vessels. Blood. 2010 Oct 21; 116(16):3108-17. Taylor SM, Nevis KR, Park HL, Rogers GC, Rogers SL, Cook JG, Bautch VL. PMID: 20664058; PMCID: PMC2974614.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimalsCells
    42. Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer. PLoS One. 2009 Aug 07; 4(8):e6555. Kim MS, Louwagie J, Carvalho B, Terhaar Sive Droste JS, Park HL, Chae YK, Yamashita K, Liu J, Ostrow KL, Ling S, Guerrero-Preston R, Demokan S, Yalniz Z, Dalay N, Meijer GA, Van Criekinge W, Sidransky D. PMID: 19662090; PMCID: PMC2717211.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    43. Pharmacologic unmasking of epigenetically silenced genes in breast cancer. Clin Cancer Res. 2009 Feb 15; 15(4):1184-91. Ostrow KL, Park HL, Hoque MO, Kim MS, Liu J, Argani P, Westra W, Van Criekinge W, Sidransky D. PMID: 19228724; PMCID: PMC3082476.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCells
    44. The role of PGP9.5 as a tumor suppressor gene in human cancer. Int J Cancer. 2008 Aug 15; 123(4):753-9. Tokumaru Y, Yamashita K, Kim MS, Park HL, Osada M, Mori M, Sidransky D. PMID: 18512240; PMCID: PMC3069849.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    45. DCC promoter hypermethylation in esophageal squamous cell carcinoma. Int J Cancer. 2008 Jun 01; 122(11):2498-502. Park HL, Kim MS, Yamashita K, Westra W, Carvalho AL, Lee J, Jiang WW, Baek JH, Liu J, Osada M, Moon CS, Califano JA, Mori M, Sidransky D. PMID: 18302152.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    46. Genome-wide promoter analysis uncovers portions of the cancer methylome. Cancer Res. 2008 Apr 15; 68(8):2661-70. Hoque MO, Kim MS, Ostrow KL, Liu J, Wisman GB, Park HL, Poeta ML, Jeronimo C, Henrique R, Lendvai A, Schuuring E, Begum S, Rosenbaum E, Ongenaert M, Yamashita K, Califano J, Westra W, van der Zee AG, Van Criekinge W, Sidransky D. PMID: 18413733; PMCID: PMC3102297.
      View in: PubMed   Mentions: 81     Fields:    Translation:HumansCells
    47. HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma. Mol Cancer Res. 2008 Jan; 6(1):31-41. Yamashita K, Kim MS, Park HL, Tokumaru Y, Osada M, Inoue H, Mori M, Sidransky D. PMID: 18234960.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    48. Alterations of GPI transamidase subunits in head and neck squamous carcinoma. Mol Cancer. 2007 Nov 21; 6:74. Jiang WW, Zahurak M, Zhou ZT, Park HL, Guo ZM, Wu GJ, Sidransky D, Trink B, Califano JA. PMID: 18028549; PMCID: PMC2204038.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    49. A promoter methylation pattern in the N-methyl-D-aspartate receptor 2B gene predicts poor prognosis in esophageal squamous cell carcinoma. Clin Cancer Res. 2007 Nov 15; 13(22 Pt 1):6658-65. Kim MS, Yamashita K, Chae YK, Tokumaru Y, Chang X, Zahurak M, Osada M, Park HL, Chuang A, Califano JA, Sidransky D. PMID: 18006766.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    50. Quantitative hypermethylation of NMDAR2B in human gastric cancer. Int J Cancer. 2007 Nov 01; 121(9):1994-2000. Liu JW, Kim MS, Nagpal J, Yamashita K, Poeta L, Chang X, Lee J, Park HL, Jeronimo C, Westra WH, Mori M, Moon C, Trink B, Sidransky D. PMID: 17620329.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    51. A p53-type response element in the GDF15 promoter confers high specificity for p53 activation. Biochem Biophys Res Commun. 2007 Mar 23; 354(4):913-8. Osada M, Park HL, Park MJ, Liu JW, Wu G, Trink B, Sidransky D. PMID: 17276395; PMCID: PMC1975780.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCells
    52. Increased plasma DNA integrity index in head and neck cancer patients. Int J Cancer. 2006 Dec 01; 119(11):2673-6. Jiang WW, Zahurak M, Goldenberg D, Milman Y, Park HL, Westra WH, Koch W, Sidransky D, Califano J. PMID: 16991120.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    53. Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma. Cancer Res. 2006 Oct 01; 66(19):9401-7. Carvalho AL, Chuang A, Jiang WW, Lee J, Begum S, Poeta L, Zhao M, Jerónimo C, Henrique R, Nayak CS, Park HL, Brait MR, Liu C, Zhou S, Koch W, Fazio VM, Ratovitski E, Trink B, Westra W, Sidransky D, Moon CS, Califano JA. PMID: 17018594.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    54. N-methyl-D-aspartate receptor type 2B is epigenetically inactivated and exhibits tumor-suppressive activity in human esophageal cancer. Cancer Res. 2006 Apr 01; 66(7):3409-18. Kim MS, Yamashita K, Baek JH, Park HL, Carvalho AL, Osada M, Hoque MO, Upadhyay S, Mori M, Moon C, Sidransky D. PMID: 16585162.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCells
    55. PGP9.5 methylation in diffuse-type gastric cancer. Cancer Res. 2006 Apr 01; 66(7):3921-7. Yamashita K, Park HL, Kim MS, Osada M, Tokumaru Y, Inoue H, Mori M, Sidransky D. PMID: 16585221.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    56. A novel response element confers p63- and p73-specific activation of the WNT4 promoter. Biochem Biophys Res Commun. 2006 Jan 27; 339(4):1120-8. Osada M, Park HL, Nagakawa Y, Begum S, Yamashita K, Wu G, Kim MS, Trink B, Sidransky D. PMID: 16343436.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    57. p63-specific activation of the BPAG-1e promoter. J Invest Dermatol. 2005 Jul; 125(1):52-60. Osada M, Nagakawa Y, Park HL, Yamashita K, Wu G, Kim MS, Fomenkov A, Trink B, Sidransky D. PMID: 15982302.
      View in: PubMed   Mentions: 18     Fields:    Translation:AnimalsCells
    58. Differential recognition of response elements determines target gene specificity for p53 and p63. Mol Cell Biol. 2005 Jul; 25(14):6077-89. Osada M, Park HL, Nagakawa Y, Yamashita K, Fomenkov A, Kim MS, Wu G, Nomoto S, Trink B, Sidransky D. PMID: 15988020; PMCID: PMC1168821.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansAnimalsCells
    59. PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma. Cancer Res. 2005 Jun 01; 65(11):4963-8. Mandelker DL, Yamashita K, Tokumaru Y, Mimori K, Howard DL, Tanaka Y, Carvalho AL, Jiang WW, Park HL, Kim MS, Osada M, Mori M, Sidransky D. PMID: 15930319.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansCells
    60. Altered sumoylation of p63alpha contributes to the split-hand/foot malformation phenotype. Cell Cycle. 2004 Dec; 3(12):1587-96. Huang YP, Wu G, Guo Z, Osada M, Fomenkov T, Park HL, Trink B, Sidransky D, Fomenkov A, Ratovitski EA. PMID: 15539951.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCells
    Hannah's Networks
    Concepts (270)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (49)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCI Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-34-g86efa0e9 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California